No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Contineum Therapeutics Sets Executive Severance Plan
Stifel Nicolaus Sticks to Its Buy Rating for Contineum Therapeutics, Inc. Class A (CTNM)
Express News | Contineum Therapeutics Announces Appointment of Troy Ignelzi to Board of Directors
Contineum Therapeutics, Inc. Class A (CTNM) Gets a Buy From RBC Capital
Contineum Therapeutics | 10-Q: Quarterly report
Express News | Contineum Therapeutics Q3 EPS $(3.55), Cash Position $117.9M
No Data